Compare SAIC & LGND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SAIC | LGND |
|---|---|---|
| Founded | 1969 | 1987 |
| Country | United States | United States |
| Employees | N/A | 68 |
| Industry | EDP Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.3B | 3.7B |
| IPO Year | 2013 | N/A |
| Metric | SAIC | LGND |
|---|---|---|
| Price | $115.60 | $252.98 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 8 | 7 |
| Target Price | $110.50 | ★ $256.29 |
| AVG Volume (30 Days) | ★ 536.5K | 159.7K |
| Earning Date | 06-01-2026 | 05-07-2026 |
| Dividend Yield | ★ 1.56% | N/A |
| EPS Growth | ★ 7.39 | N/A |
| EPS | ★ 2.61 | N/A |
| Revenue | ★ $7,262,000,000.00 | N/A |
| Revenue This Year | N/A | $1.25 |
| Revenue Next Year | $1.65 | $19.41 |
| P/E Ratio | ★ $44.03 | $76.27 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $81.08 | $111.72 |
| 52 Week High | $123.41 | $258.57 |
| Indicator | SAIC | LGND |
|---|---|---|
| Relative Strength Index (RSI) | 72.56 | 72.95 |
| Support Level | $92.46 | $199.97 |
| Resistance Level | $123.41 | N/A |
| Average True Range (ATR) | 4.56 | 7.34 |
| MACD | 0.60 | 2.33 |
| Stochastic Oscillator | 69.17 | 87.91 |
Science Applications International Corp provides technical, engineering, and enterprise IT services mainly to the U.S. government. Specifically, it offers end-to-end solutions spanning the design, development, integration, deployment, management and operations, sustainment, and security of the customer's entire IT infrastructure. The company has two reportable segments which include Defense and Intelligence and the Civilian segment. Maximum revenue is generated from its Defense and Intelligence segment, which provides a diverse portfolio of national security solutions to the Department of Defence (DoD) and the Intelligence Community of the United States Government. The Civilian segment provides solutions to the civilian markets, encompassing federal, state, and local governments.
Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.